Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
AMBROXOL HYDROCHLORIDE
Boehringer Ingelheim Limited
R02AD
AMBROXOL HYDROCHLORIDE
20 Milligram
Lozenges
Product not subject to medical prescription
ANESTHETICS, LOCAL
Transfer Pending
2012-06-01
ABCD 1. WHAT LYSOPADOL LEMON IS AND WHAT IT IS USED FOR Lysopadol Lemon contains the active substance ambroxol hydrochloride. The active substance is the part of the lozenges that gives the therapeutic effect you need. Lysopadol Lemon has a local anaesthetic effect which relieves the pain in acute sore throat. Lysopadol Lemon is used to relieve the pain in acute sore throat. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LYSOPADOL LEMON DO NOT TAKE LYSOPADOL LEMON – If you are allergic to ambroxol hydrochloride or any of the other ingredients of this medicine (listed in section 6) – If you suffer from the rare hereditary conditions of fructose intolerance WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Lysopadol Lemon – You should not use Lysopadol Lemon for more than 3 days. If you still have symptoms after 3 days or if you have a high fever, please consult a doctor – If you have been told by your doctor that you have an intolerance to some types of sugar, contact your doctor before taking this medicinal product. See also “Lysopadol Lemon contains sorbitol and sucrose ” – If you have liver or kidney problems, ask your doctor before using Lysopadol Lemon – Lysopadol Lemon is not suitable for the treatment of painful lesions in the mouth (e.g. ulcers or sores). If you have mouth ulcers please consult a doctor – Shortness of breath (dyspnoea) may be observed due to an underlying condition (e.g. swollen throat). Another reason could be a feeling of tightness in the throat due to the local anaesthetic effect of Lysopadol Lemon. A further cause could be an allergic reaction which may also cause your mouth and throat to swell – Your throat and mouth may feel less sensitive than usual (numb) – There have been reports of severe skin reactions associated with the administration of ambroxol hydrochloride. If you develop a skin rash (including lesions of the mucous membranes such as mouth, throat, nose, eyes, genitals), stop using Lysopadol Lemon and contact your doctor immediately C Läs hela dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lysopadol Lemon 20 mg Lozenges 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One lozenge contains 20 mg of ambroxol hydrochloride. Excipient(s) with known effect: Each lozenge contains 1.37 g sorbitol (E420) and 6.3 mg sucrose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Lozenge Round, white tablet, both sides flat with bevelled edges 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pain relief in acute sore throat. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults and children over 12 years of age: up to 6 lozenges to be sucked per day, with a maximum of 1 lozenge per dose. Lysopadol Lemon 20 mg Lozenges can be used for up to 3 days. In case of persistent symptoms or high fever, the patient should consult a doctor. _Paediatric population_ Lysopadol Lemon 20 mg Lozenges should not be used in children under 12 years of age. Method of administration Oromucosal use. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Patients with fructose intolerance should not receive Lysopadol Lemon 20 mg Lozenges since they contain significant amounts of sorbitol. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Lysopadol Lemon 20 mg Lozenges can be used for up to 3 days. If symptoms worsen or still persist after 3 days or if the patient has a high fever, a doctor should be consulted. There have been reports of severe skin reactions such as erythema multiforme, Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and acute generalised exanthematous pustulosis (AGEP) associated with the administration H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ Läs hela dokumentet